Live feed
Filing
SC 13G
SC 13G0001193125-18-308484·Tempest Therapeutics, Inc.
Schedule 13G ownership disclosure
OvaScience, Inc.
Security class unavailable · CUSIP: 69014Q101
Event date: 2018-10-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-308484
- Form type
- SC 13G
- Filer
- Tempest Therapeutics, Inc.
- CIK
- CIK 1544227
- Filed
- Oct 26, 2018
- Reporting period
- Oct 16, 2018
- Description
- Schedule 13G beneficial ownership